Selected research · Industry
Protein sequence design and deimmunization
Scientific question
Can protein sequences be redesigned to lower predicted immunogenicity while preserving structure and function?
Why it matters
Therapeutic proteins that provoke unwanted immune responses can lose efficacy or safety. Computational deimmunization offers a way to screen for lower-risk sequence variants before wet-lab validation.
Approach
Combined Markov chain Monte Carlo (MCMC) sequence sampling with NetMHC-predicted immunogenicity scores and inverse-folding scores from ESM-IF1 and ProteinMPNN, balancing immunogenicity reduction against structural and functional constraints. Separately, added property guidance to ADFLIP to steer deimmunized sequence design.
My contribution
- Implemented the MCMC optimization loop combining NetMHC and inverse-folding scores under competing constraints
- Added property guidance to ADFLIP for deimmunized sequence design
Evidence & results
70%+
NetMHC score reduction
on monomer Griffithsin
10%
TM/activity increase
reported on the same design
40%
NetMHC score reduction
on SaCas9, via ADFLIP property guidance
Methods & tools
Completed at Insmed Inc. described only at the level of detail present in Thu's public résumé.